The global nasal cannula market is expanding as healthcare providers respond to rising respiratory disorders, growing demand for oxygen therapy, and improvements in hospital and home healthcare services. Nasal cannulas are widely used to deliver supplemental oxygen to patients in hospitals, ambulatory healthcare facilities, and homecare settings. Manufacturers are focusing on patient comfort, disposable products, and advanced high-flow oxygen delivery systems.
According to Fortune Business Insights, the global nasal cannula market size was valued at USD 8.07 billion in 2025. The market is projected to grow from USD 8.71 billion in 2026 to USD 16.04 billion by 2034, exhibiting a CAGR of 7.93% during the forecast period.
Why Is the Nasal Cannula Market Growing?
The market is growing because respiratory conditions such as chronic obstructive pulmonary disease (COPD), asthma, pneumonia, and other breathing disorders increase the need for oxygen support. Hospitals and emergency departments use nasal cannulas for routine oxygen delivery, while high-flow systems are increasingly used in critical care environments.
The expansion of home healthcare is another important factor. Patients who require long-term oxygen therapy can use nasal cannulas with compatible oxygen delivery equipment, supporting demand beyond traditional hospital settings.
Key Market Trends
Increasing Adoption of High-Flow Nasal Cannulas
High-flow nasal cannula systems deliver heated and humidified oxygen at higher flow rates. Their use in intensive care units and emergency departments is supporting product development and adoption in advanced respiratory care.
Growing Demand for Comfortable and Disposable Products
Manufacturers are developing soft-tip designs, flexible tubing, and medical-grade materials to improve patient comfort. Disposable nasal cannulas are also used to support infection-control practices in healthcare facilities.
Expansion of Home-Based Oxygen Therapy
Portable oxygen equipment and home respiratory care services are creating opportunities for lightweight nasal cannulas designed for extended use and improved mobility.
Market Dynamics
Driver: Rising respiratory disease prevalence and increasing oxygen therapy requirements are supporting market demand.
Restraint: Alternative oxygen delivery devices, including oxygen masks and other respiratory support systems, may limit nasal cannula use in certain clinical situations.
Opportunity: Expanding home healthcare, portable oxygen systems, and remote respiratory monitoring offer growth opportunities for manufacturers.
Challenge: Medical-grade material costs, product quality requirements, and infection-control regulations can increase manufacturing and compliance expenses.
Read the full report: https://www.fortunebusinessinsights.com/nasal-cannula-market-116938
Market Segmentation Analysis
The nasal cannula market can be segmented by type, material, end-use, and region.
By type: Low-flow and high-flow nasal cannulas.
By material: Silicone, polyvinyl chloride (PVC), and other materials.
By end-use: Hospitals and ambulatory healthcare services, with demand also supported by homecare applications.
Low-flow nasal cannulas have broad use in routine oxygen therapy, while high-flow systems are gaining attention in critical care. Silicone products are valued for flexibility and comfort, and hospitals remain important purchasers because of their ongoing need for oxygen delivery devices.
Regional Insights
North America led the global nasal cannula market with approximately 38% share in 2025, supported by established healthcare infrastructure and demand for respiratory treatment products. Europe accounted for around 27%, while Asia Pacific held approximately 25%. Asia Pacific offers growth opportunities as healthcare infrastructure develops and demand for respiratory care increases across countries such as China, India, and Japan.
Competitive Landscape
Key companies operating in the nasal cannula market include:
Allied Medical LLC
Teleflex Incorporated
Flexicare (Group) Limited
Vapotherm
ResMed
Fisher & Paykel Healthcare Limited
Well Lead Medical Co., Ltd.
SunMED, LLC
Companies compete through product design, material improvements, distribution networks, and the development of respiratory support technologies.
Investment Analysis and Opportunities
Investment opportunities are emerging in high-flow oxygen therapy systems, homecare respiratory products, and patient-comfort-focused designs. Manufacturers can also explore improved tubing, flexible connectors, and products compatible with portable oxygen equipment. Expanding healthcare access in developing markets may further support demand for cost-effective oxygen delivery accessories.
Future Outlook
The nasal cannula market is projected to increase from USD 8.71 billion in 2026 to USD 16.04 billion by 2034, registering a CAGR of 7.93% from 2026 to 2034, according to Fortune Business Insights. Growing demand for respiratory care, expansion of home oxygen therapy, and continued product innovation are expected to support the market over the forecast period.
Request a Sample Report
https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/nasal-cannula-market-116938
What’s Driving Japan’s Market? Discover the Latest Nasal Cannula Market Insights